BioLargo (BLGO) Competitors $0.19 +0.01 (+3.44%) As of 11:06 AM Eastern Add Compare Share Share Competitors Stock AnalysisChartCompetitorsHeadlinesSEC FilingsShort InterestTrendsBuy This Stock BLGO vs. AMTX, VGAS, LODE, ORGN, TSE, ZTEK, ALTO, LNZA, FSI, and LOOPShould you be buying BioLargo stock or one of its competitors? The main competitors of BioLargo include Aemetis (AMTX), Verde Clean Fuels (VGAS), Comstock (LODE), Origin Materials (ORGN), Trinseo (TSE), Zentek (ZTEK), Alto Ingredients (ALTO), LanzaTech Global (LNZA), Flexible Solutions International (FSI), and Loop Industries (LOOP). These companies are all part of the "chemicals" industry. BioLargo vs. Its Competitors Aemetis Verde Clean Fuels Comstock Origin Materials Trinseo Zentek Alto Ingredients LanzaTech Global Flexible Solutions International Loop Industries BioLargo (NASDAQ:BLGO) and Aemetis (NASDAQ:AMTX) are both small-cap chemicals companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, earnings, media sentiment, institutional ownership, analyst recommendations, profitability, dividends and risk. Which has more volatility and risk, BLGO or AMTX? BioLargo has a beta of 0.11, indicating that its stock price is 89% less volatile than the S&P 500. Comparatively, Aemetis has a beta of 1.57, indicating that its stock price is 57% more volatile than the S&P 500. Which has better earnings and valuation, BLGO or AMTX? BioLargo has higher earnings, but lower revenue than Aemetis. BioLargo is trading at a lower price-to-earnings ratio than Aemetis, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioBioLargo$12.23M4.75-$3.50M-$0.01-18.95Aemetis$237.89M0.72-$87.54M-$1.87-1.65 Is BLGO or AMTX more profitable? BioLargo has a net margin of -11.45% compared to Aemetis' net margin of -36.92%. Aemetis' return on equity of 0.00% beat BioLargo's return on equity.Company Net Margins Return on Equity Return on Assets BioLargo-11.45% -39.90% -22.06% Aemetis -36.92%N/A -35.80% Do institutionals and insiders believe in BLGO or AMTX? 0.0% of BioLargo shares are held by institutional investors. Comparatively, 27.0% of Aemetis shares are held by institutional investors. 19.3% of BioLargo shares are held by company insiders. Comparatively, 14.7% of Aemetis shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth. Do analysts prefer BLGO or AMTX? Aemetis has a consensus target price of $13.63, indicating a potential upside of 341.65%. Given Aemetis' stronger consensus rating and higher possible upside, analysts clearly believe Aemetis is more favorable than BioLargo.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score BioLargo 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Aemetis 0 Sell rating(s) 1 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 2.75 Does the media prefer BLGO or AMTX? In the previous week, BioLargo and BioLargo both had 1 articles in the media. Aemetis' average media sentiment score of 1.87 beat BioLargo's score of 0.46 indicating that Aemetis is being referred to more favorably in the news media. Company Overall Sentiment BioLargo Neutral Aemetis Very Positive SummaryAemetis beats BioLargo on 9 of the 15 factors compared between the two stocks. Get BioLargo News Delivered to You Automatically Sign up to receive the latest news and ratings for BLGO and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding BLGO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart BLGO vs. The Competition Export to ExcelMetricBioLargoChemicals & allied products IndustryConstruction SectorNASDAQ ExchangeMarket Cap$58.11M$11.86B$9.56B$9.50BDividend YieldN/A1.09%2.01%3.99%P/E Ratio-18.95N/A16.5519.98Price / Sales4.753.44104.25101.04Price / CashN/A14.8015.1258.97Price / Book18.9510.834.705.87Net Income-$3.50M$989.69M$620.50M$258.50M7 Day Performance-0.26%-0.55%2.23%1.93%1 Month Performance-8.45%-4.61%4.38%12.29%1 Year Performance-28.30%-14.45%101.94%19.06% BioLargo Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)BLGOBioLargo0.4506 of 5 stars$0.19+3.4%N/A-30.7%$58.11M$12.23M-18.9530AMTXAemetis2.4247 of 5 stars$3.14+5.4%$13.63+333.9%-2.4%$173.86M$237.89M-1.68160Positive NewsUpcoming EarningsVGASVerde Clean Fuels0.2598 of 5 stars$3.28+1.2%N/A-26.2%$146.12MN/A-6.832Positive NewsLODEComstock1.3296 of 5 stars$3.72+0.3%$26.00+598.9%+142.0%$120.59M$3.38M-31.0030Positive NewsORGNOrigin Materials2.1053 of 5 stars$0.75+24.8%$1.50+101.2%-21.9%$111.82M$31.28M-1.11160Positive NewsHigh Trading VolumeTSETrinseo1.3621 of 5 stars$3.11+7.4%N/A+10.5%$110.69M$3.39B-0.312,950ZTEKZentek0.6097 of 5 stars$0.92+4.9%N/A-10.5%$96.69M$1.22M-15.3924ALTOAlto Ingredients3.26 of 5 stars$1.24+0.8%$5.50+343.5%-21.3%$95.00M$965.26M-1.51420News CoverageLNZALanzaTech Global2.4706 of 5 stars$0.36+12.6%$2.00+455.9%-70.9%$83.46M$49.59M-0.543Gap UpHigh Trading VolumeFSIFlexible Solutions International2.9885 of 5 stars$5.76+4.2%N/A+183.9%$72.85M$36.48M17.4640LOOPLoop Industries1.9538 of 5 stars$1.23flatN/A-21.3%$58.70M$10.89M-4.3990Gap Up Related Companies and Tools Related Companies AMTX Competitors VGAS Competitors LODE Competitors ORGN Competitors TSE Competitors ZTEK Competitors ALTO Competitors LNZA Competitors FSI Competitors LOOP Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:BLGO) was last updated on 7/25/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | SponsoredTrump’s betrayal exposed Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredTreasury Secretary Bessent Is Betting Big on GoldWhen the U.S. Treasury Secretary’s largest personal investment is gold — that’s a signal. Now a veteran gol...Golden Portfolio | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding BioLargo, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share BioLargo With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.